The open-source clinical reporting playbook: How four leading pharma companies transformed drug de

Four pharmaceutical giants completed the industry’s first wave of R-based regulatory submissions in 2023-2024, achieving 25-50% faster preparation times while proving that open-source clinical reporting meets FDA and EMA standards. Roche, GSK, Johnson & Johnson, and Novo Nordisk each demonstrate that open-source adoption delivers measurable business results.

First Name

Last Name

Phone Number

Job Title

Company Name

Country

What is the primary hurdle preventing your organization from scaling its AI and data science initiatives?

If you came across a strong solution, when would be the right time to evaluate or implement it?

If you wish to opt out of data collection, marketing communications, or any other services provided by Posit privacy policy, please complete and submit the form below.

@Posit

The open-source clinical reporting playbook: How four leading pharma companies transformed drug de

Subscribe To Our Newsletter